The Foundation Fighting Blindness seeks proposals toward the Translational Research Acceleration Program (TRAP). The Foundation Fighting Blindness’ unique TRAP program accelerates preclinical translational research targeted at preventing, treating, or curing blindness resulting from inherited retinal degenerative disease (IRD) and dry age-related macular degeneration (dAMD). It leverages a proactive program management structure, including a hands-on advisory committee with expertise in drug development, retinal clinical therapies, commercialization, regulatory guidance, intellectual property, and partnerships, providing a catalyst that helps move technology into clinical use. People with inherited retinal degenerations need an increased number of therapies to combat the diversity, complexity, and uniqueness of inherited retinal diseases and dry age-related macular degeneration.
The Research Priority Areas
(1) Novel Medical Therapies – approaches that use chemistry, biology, and bioengineering to formulate new therapies that mitigate inherited retinal degenerations and dry age-related macular degenerations;
(2) Genetic Technologies – the manipulation and modification of human gene expression to alter the biological properties of living cells/tissues with the goal of providing therapeutic solutions;
(3) Regenerative Medicine – the development, regeneration, and employment of human cells, tissues, and cellular/tissue-based products for the restoration of retinal function and vision
Note: Research and technologies that fall outside of the scope of these areas may be considered with adequate preliminary data and justification.
For more information about Research Priority Areas, see https://fighting-blindness-dot-org.s3.amazonaws.com/zm85c1ztw6bg8c593teljmi2nncl?response-content-disposition=inline%3B%20filename%3D%222023%2003%2028_Overview%20of%20Funding%20Opportunity%20-%20Translational%20Research%20Acceleration%20Program%20Award.pdf%22%3B%20filename%2A%3DUTF-8%27%272023%252003%252028_Overview%2520of%2520Funding%2520Opportunity%2520-%2520Translational%2520Research%2520Acceleration%2520Program%2520Award.pdf&response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAIZQ4HBPK4TAKDHGA%2F20230416%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20230416T102933Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=7b47a2e5844132223cf3c998af6b0d9cb4b6b368912e531e12c9b5fef74857a4#page=2.
For Allowable Costs, see https://fighting-blindness-dot-org.s3.amazonaws.com/1b0tqkqhcpdddh33vcknjnzuf1e2?response-content-disposition=inline%3B%20filename%3D%222022%2004%2022_FFB_TRAP_Application.pdf%22%3B%20filename%2A%3DUTF-8%27%272022%252004%252022_FFB_TRAP_Application.pdf&response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAIZQ4HBPK4TAKDHGA%2F20230416%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20230416T102935Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=3c25a238b7eae21e7a6e4f0216295656a7436fd8e9b275ee478316430a37b395#page=3.